Inscription Capital’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,746
Closed -$67.1K 799
2025
Q4
$67.1K Buy
+14,746
New +$75.7K 0.01% 673

Other funds holding TBI

Inscription Capital's TBI Position: Q1 2026 in Review

Inscription Capital sold out of Trueblue (TBI) in Q1 2026, closing a stake of 14,746 shares — an estimated $67.1K sold.

Inscription Capital first reported a position in TBI in Q4 2025 and held it in 1 quarter. The position peaked at $67.1K in Q4 2025. 105 funds tracked by Wall St. Rank hold TBI as of Q1 2026.

  • Inscription Capital reported no remaining Trueblue position as of Q1 2026 after selling out during the quarter.
  • Inscription Capital sold 14,746 Trueblue shares in Q1 2026, an estimated $67.1K.
  • Inscription Capital first reported a position in Trueblue in Q4 2025 and held it in 1 quarter.
  • Inscription Capital's Trueblue position peaked at $67.1K in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Trueblue as of Q1 2026.

Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.